Position in KRYS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$20,251,926
+$8,274,403 QoQ
Shares Held
54,489
+17.5% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#54
of 419 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KRYS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bridgewater Associates, LP holds $347,338,125 across 26 Biotechnology names. KRYS ranks #8 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
455,392 | $48,553,895 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
463,146 | $36,250,437 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
448,143 | $33,377,690 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
51,333 | $32,008,178 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
99,584 | $29,977,771 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
429,904 | $23,618,925 | |
| 7 | EXEL |
Exelixis, Inc.
|
400,859 | $21,810,738 | |
| 8 | KRYS |
Krystal Biotech, Inc.
This page
|
54,489 | $20,251,926 |
All Filings in KRYS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,251,926 | 54,489 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $11,977,523 | 46,367 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,469,098 | 10,015 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,716,401 | 9,723 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||